Celiac Disease Complicated by a Rare, Ulcerative Duodenal Adenocarcinoma

Nada Boutrid^{1, 2}, Hakim Rahmoune^{1, 2,} , Mounira Amrane¹, Abderraouf Bataiche³ and Naouel Lemdaoui³

¹LMCVGN Research Laboratory; Setif-1 University, Algeria

²Department of Pediatrics, University Hospital of Setif; Setif-1 University, Algeria

³General Surgery “B” Department, Ben Badis University Hospital of Constantine, Algeria

Cite this paper:
Nada Boutrid, Hakim Rahmoune, Mounira Amrane, Abderraouf Bataiche and Naouel Lemdaoui. Celiac Disease Complicated by a Rare, Ulcerative Duodenal Adenocarcinoma. International Journal of Celiac Disease. 2020; 8(2):54-55. doi: 10.12691/ijcd-8-2-3

Abstract

Celiac Disease (CD) is an autoimmune condition that is well-known to be associated with increased risk of malignancies, specifically gastro-intestinal neoplasms. We report a case of a young male patient with CD presenting with an ulcerative duodenal adenocarcinoma, successfully operated by cephalic pancreaticoduodenectomy.

Keywords:
celiac disease histopathology small bowel adenocarcinoma

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Spijkerman M, Tan IL, Kolkman JJ, Withoff S, Wijmenga C, Visschedijk MC, Weersma RK. A large variety of clinical features and concomitant disorders in celiac disease–A cohort study in the Netherlands. Digestive and Liver Disease. 2016 May 1; 48(5): 499-505.
[2]	Freeman HJ. Celiac disease and selected long-term health issues. Maturitas. 2012 Nov 1; 73(3): 206-11.
[3]	Rahmoune H, Boutrid N, Amrane M, Ouhida S, Abdellouche D, Bioud B. Celiac Disease & Lymphoproliferative Malignancy at Adulthood. International Journal of Celiac Disease. 2018; 6(2): 47-8.
[4]	Ludvigsson JF. Mortality and malignancy in celiac disease. Gastrointestinal Endoscopy Clinics. 2012 Oct 1; 22(4): 705-22.
[5]	Rubio-Tapia A, Ludvigsson JF, Brantner TL, Rajkumar SV, Landgren O, Murray JA. Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES III. BMC gastroenterology. 2016 Dec; 16(1): 136.
[6]	Marchi E, O’Connor OA. The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management. CA: A Cancer Journal for Clinicians. 2020 Jan;70(1):47-70.
[7]	Han Y, Chen W, Li P, Ye J. Association between coeliac disease and risk of any malignancy and gastrointestinal malignancy: a meta-analysis. Medicine. 2015 Sep; 94(38).
[8]	Caio G, Volta U, Ursini F, Manfredini R, De Giorgio R. Small bowel adenocarcinoma as a complication of celiac disease: clinical and diagnostic features. BMC Gastroenterol. 2019; 19(1):45.
[9]	Aparicio T, Henriques J, Manfredi S, et al. Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients [published online ahead of print, 2020 Jan 7]. Int J Cancer. 2020.
[10]	Pisello F, Geraci G, Li Volsi F, Stassi F, Modica G, Sciumè C. Duodenal Signet Ring Cell Carcinoma in a Celiac Patient. Case Rep Gastroenterol. 2009; 3(1):49‐55.
[11]	Szakács Z, Gede N, Gyöngyi Z, Solymár M, Csupor D, Erőss B, Vincze Á, Mikó A, Vasas A, Szapáry L, Dobszai D. A call for research on the prognostic role of follow-up histology in celiac disease: A systematic review. Frontiers in Physiology. 2019; 10.
[12]	Dusunceli Atman E, Erden A, Ustuner E, Uzun C, Bektas M. MRI Findings of Intrinsic and Extrinsic Duodenal Abnormalities and Variations. Korean J Radiol. 2015; 16(6): 1240‐1252.